Claret’s latest fundraise exceeded its €500 million target, increasing the scale of capital available for growth lending to European companies.

European growth debt fund Claret Capital Partners raises €575M, with a third earmarked for biotech, medtech and diagnostics deals.

Claret’s latest fundraise exceeded its €500 million target, increasing the scale of capital available for growth lending to European companies.